342613-80-3

Usage

Uses

Used in Pharmaceutical Industry:
Imidazo[1,2-a]pyridine-7-methanol (9CI) is utilized as a pharmaceutical intermediate for the development of various drugs. Its unique structure and potential biological activities make it a promising candidate for the synthesis of new therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, Imidazo[1,2-a]pyridine-7-methanol (9CI) serves as a key component in the formulation of pesticides and other agrochemical products. Its ability to interact with biological systems contributes to its effectiveness in this application.
Used in Organic Synthesis:
Imidazo[1,2-a]pyridine-7-methanol (9CI) is employed as a building block in the synthesis of other organic compounds with diverse applications. Its versatile structure allows for the creation of a wide range of molecules for various industries, including materials science and specialty chemicals.
Used in Research and Development:
Imidazo[1,2-a]pyridine-7-methanol (9CI) is also used in research and development settings to study its pharmacological properties and explore its potential as a therapeutic agent. Imidazo[1,2-a]pyridine-7-methanol (9CI)'s unique structure and biological activities make it an interesting subject for scientific investigation.

Upstream product

• 372147-49-4 imidazo[1,2-a]pyridine-7-carboxylic acid ethyl ester 
• 13362-30-6 2-amino-4-ethoxycarbonyl-pyridine 
• 107-20-0 2-chloroethanal 
• 105250-17-7 2-amino-4-hydroxymethylpyridine 

Downstream Products

• 760900-54-7 7-(chloromethyl)imidazo[1,2-a]pyridine 
• 1186514-46-4 N₃-(imidazo[1,2-a]pyridin-7-ylmethyl)-N₅-isobutyl-N₅,4'-dimethylbiphenyl-3,5-dicarboxamide 
• 1036991-50-0 1-(imidazo[1,2-a] pyridin-7-yl)ethan-1-one 
• 1251899-79-2 1-[3-(7-{[2-(2-methoxyethylamino)ethoxyimino]methyl}imidazo[1,2-a]pyridin-3-yl)phenyl]-3-(2,2,2-trifluoroethyl)urea 
• 1251899-85-0 1-(3-{7-[(2-piperidin-4-ylethoxyimino)methyl]imidazo[1,2-a]pyridin-3-yl}phenyl)-3-(2,2,2-trifluoroethyl)urea 
• 1251899-95-2 C₂₉H₃₅F₃N₆O₄ 
• 1251899-78-1 1-[3-(7-{[2-(2-methanesulfonylethylamino)ethoxyimino]methyl}imidazo[1,2-a]pyridin-3-yl)phenyl]-3-(2,2,2-trifluoroethyl)urea 
• 1251899-94-1 C₁₉H₁₇ClF₃N₅O₂ 
• 1251899-82-7 1-[3-(7-{[3-(4-methylpiperazin-1-yl)propoxyimino]methyl}imidazo[1,2-a]pyridin-3-yl)phenyl]3-(2,2,2-trifluoroethyl)urea 
• 1251899-93-0 C₂₀H₁₉ClF₃N₅O₂ 
• 1251899-76-9 1-[3-(7-{cyclopropylhydroxyiminomethyl}imidazo[1,2-a]pyridin-3-yl)phenyl]-3-(2,2,2-trifluoroethyl)urea 
• 1251899-81-6 1-(3-{7-[(pyridin-3-ylmethoxyimino)methyl]imidazo[1,2-a]pyridin-3-yl}phenyl)-3-(2,2,2-trifluoroethyl)urea 
• 1251899-80-5 1-(3-{7-[(2-hydroxyethoxyimino)methyl]imidazo[1,2-a]pyridin-3-yl}phenyl)-3-(2,2,2-trifluoroethyl)urea 
• 1036988-07-4 C₁₇H₁₄F₃N₅O₂ 

Relevant academic research and scientific papers

ISOQUINOLINE DERIVATIVES AS PROTEIN KINASE INHIBITORS

The present invention relates to a compound suitable for use as a kinase inhibitor

AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF

Compounds are provided according to formula (1 ) : where A, B, W, X', L, R1, R3, R4b, and m' are as defined herein. Provided compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, cognitive disorders, anxiety, depression, and others.

IMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASES

The invention relates to new bicyclic heterocyclic derivative compounds, to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

PIPERIDINE DERIVATIVES USEFUL AS HISTAMINE H3 ANTAGONISTS

Disclosed are novel compounds of the formula (I) or a pharmaceutically acceptable salt thereof, wherein: M1 and M3 are CH or N; M2 is CH, CF or N; Y is -C(=O)-, -C(=S)-, -(CH2)q-, -C(=NOR7)

Heterocyclization of functionalized vinylic derivatives of imidazo[1,2-α]pyridines

Heterocyclization of functionalized vinylic derivatives of imidazo[1,2-α]pyridines was explored experimentally and theoretically using semiempirical AM1 and ab initio methods. A range of functionalized vinylic derivatives (azido, amino, and carbodiimide groups) were prepared for conversion into pyrroloazaindoles 19-22, imidazo[1,x]-; (x=5, 6, 7, 8), [2,6]-, and [2,7]naphthyridines 28-30, 35-38 by thermal reaction. In the case of vinylic groups in the 5 position, peri annulation also was observed. The experimental and theoretical data are compared and discussed.